Do you store tirzepatide in the fridge? What Mounjaro users need to know

Tirzepatide (Mounjaro) KwikPens must be stored in the refrigerator at 2°C–8°C, cold but not frozen.
A limited room-temperature window exists once the pen is out of the fridge; the exact duration is specified in your Patient Information Leaflet.
Freezing ruins the medicine, a pen that has been frozen should not be used.
Injection sites (abdomen, thigh, upper arm) should be rotated each week; let the pen reach room temperature before injecting for comfort.

Yes — tirzepatide (Mounjaro) must be kept refrigerated between 2°C and 8°C until you are ready to use it. That is the storage condition stated in the Mounjaro Summary of Product Characteristics on the eMC, and it applies from the moment your pen arrives to the moment you take it out for injection. Once out of the fridge, a limited room-temperature window applies — the exact duration and conditions are set out in your Patient Information Leaflet, and your prescriber is the right person to clarify those details for your situation. As a prescription-only medicine, tirzepatide requires clinical assessment before it can be supplied; a prescriber decides suitability for each individual.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The decisions every Mounjaro user faces around storage, and how to get them right

Why the fridge matters more than it might seem

Tirzepatide is a biological medicine (a dual GIP and GLP-1 receptor agonist) and biological medicines are sensitive to temperature in ways that small-molecule tablets are not. Storing a Mounjaro pen outside its required 2°C–8°C range does not just reduce its potency: there is no reliable way to tell from looking at the liquid whether degradation has occurred. The solution should be clear and colourless. If it looks cloudy, discoloured or contains particles, do not use it.

A question our prescribers hear most weeks is whether tirzepatide needs to be kept in the fridge and what happens if it was accidentally left on the kitchen counter overnight. The honest answer is: consult your Patient Information Leaflet for the precise room-temperature window and conditions, and contact your prescriber or pharmacist if the pen was out for longer or was exposed to unusual heat. Erring on the side of caution with a biological medicine is always the right call.

One practical note: the back of the fridge door is not ideal. Temperatures there fluctuate more than on a middle shelf, and the pen must never freeze. Keep it away from the freezer compartment. The full storage guide for tirzepatide covers these positioning details, including what to do if your fridge runs cold.

The room-temperature decision: when is it safe to take the pen out?

You will need to remove the pen from the fridge before injecting. Injecting cold liquid can cause more discomfort at the site, so most people find it more comfortable to let the pen sit at room temperature for a short time first. The exact window (how long it can safely remain out of refrigeration) is stated in your Patient Information Leaflet, because it can differ between product presentations and strengths. This is not information to source from a forum or a general article.

The practical decision here is timing. Many people keep a simple routine: take the pen out while they make breakfast, inject before eating, return any unused pens to the fridge immediately. Structure removes the guesswork. See the NHS medicines page on tirzepatide for a patient-level overview of how the medicine is used alongside storage considerations.

If you are travelling and refrigeration is intermittent, read your Patient Information Leaflet's guidance on temporary storage conditions before you leave. The storage specifics for Mounjaro pens go into more depth on travel scenarios.

What ruins a pen, and how to avoid it

Two things consistently compromise tirzepatide pens: freezing and sustained heat exposure. A pen that has been frozen (even once, even briefly) should not be used. There is no thaw-and-recover option for a biological medicine. Equally, leaving a pen in a warm car, on a windowsill in summer or near a radiator can push it outside the acceptable range before its listed window is up.

Direct sunlight is also worth avoiding. Keep pens in their original carton, in the fridge, until needed. If you are disposing of used pens, a purpose-made sharps container is the safe and legally required route, ordinary household bins are not appropriate for used injection devices.

The detailed guide on tirzepatide fridge storage addresses what to do with a pen you suspect has been compromised, including when to contact your pharmacy. For context on the broader treatment (how Mounjaro works, what the licensed schedule looks like) the Mounjaro overview covers it.

Storage as part of a bigger clinical picture

Getting storage right matters because the clinical evidence behind tirzepatide (SURMOUNT-1, published in the New England Journal of Medicine, showing average body-weight reductions of around 20–21% at the highest dose over 72 weeks) was generated under controlled conditions that included proper medicine handling. Real-world results depend on the medicine being intact when injected. Poor storage is one of the avoidable reasons a pen might not perform as expected.

None of this is complicated once you have a routine. The decision is simple: fridge until use, room temperature for the window your leaflet specifies, then injected at the right site, rotated from the previous week. Questions about whether your specific circumstances affect storage (a medication fridge that runs cold, a week-long trip without reliable power) are exactly the kind of thing to raise with your prescriber.

If you are considering tirzepatide for weight management, or are already on treatment and have questions about how your care is reviewed, you can speak to our prescribers through a free consultation. Guidance on cost, access and what the broader treatment landscape looks like is on the weight loss treatments page. And if you are wondering how long an unopened pen can be kept once it leaves cold storage, the answer depends on conditions your leaflet describes, our guide on tirzepatide storage duration unpacks that question directly.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions